in Newswire December 5, 2018

Three Pharma Companies, Walmart Hit with Class Action Over Sale of Allegedly NDEA-Contaminated Irbesartan

by Corrado Rizzi

Last Updated on December 5, 2018

Kruk v. Aurobindo Pharma Ltd. et al

Filed: December 1, 2018 § 8:18cv2927

A class action lawsuit has been filed against four companies a consumer claims respectively made, distributed and sold carcinogen-contaminated Irbesartan.

Last Updated on December 5, 2018 — 2:12 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.